Upcoming Journal Club:
Journal Club (6)
Tuesday 26th January 2021 12.30pm EST; 5.30pm UK
To be announced
Past Journal Club Presentations:
Journal Club (5)
Tuesday 12th January 2021 12.30pm EST; 5.30pm UK
An RCT of repeated ketamine administration for chronic post-traumatic stress disorder
Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, Horn SR, Kautz M, Corniquel M, Collins KA, Bevilacqua L, Glasgow AM, Brallier J, Pietrzak RH, Murrough JW, Charney DS.
Am J Psychiatry. 2021 Jan 5: doi: 10.1176/appi.ajp.2020.20050596. Epub ahead of print. PMID: 33397139
Presenter: Adriana Feder, Associate Professor, Icahn School of Medicine, Mount Sinai, New York
Journal Club (1)
Tuesday 10th November 2020 12.30pm EST; 5.30pm UK
Morris LS, Costi S, Tan A, Stern ER, Charney DS, Murrough JW. Neuropsychopharmacology (2020), 45(6):975-981. PMID: 31896116
Presenter: Laurel Morris, Assistant Professor, Icahn School of Medicine, Mount Sinai, New York
Journal Club (2)
Tuesday 24th November 2020 12:30pm EST; 5.30pm UK
Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review.
Sakurai H, Jain F, Foster S, Pedrelli P, Mischoulon D, Fava M, Cusin C. J Affect Disord. 2020 Nov 1;276:660-666.
PMID: 32871698
Presenter: Cristina Cusin, Assistant Professor of Psychiatry, Massachusetts General Hospital
Journal Club (3)
Tuesday 8th December 2020 12:30pm EST; 5.30pm UK
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence.
McIntyre RS, Rodrigues NB, Lipsitz O, Nasri F, Gill H, Lui LM, Subramaniapillai M, Kratiuk K, Teopiz K, Ho R, Lee Y, Mansur RB, Rosenblat JD. J Psychopharmacol. 2020 Oct 11 Epub ahead of print.
PMID: 33040665
Presenter: Roger McIntyre,
Professor of Psychiatry and Pharmacology, University of Toronto
Journal Club (4)
Tuesday 22nd December 2020 12:30pm EST; 5.30pm UK
Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine.
Chen BK, Luna VM, LaGamma CT, Xu X, Deng SX, Suckow RF, Cooper TB, Shah A, Brachman RA, Mendez-David I, David DJ, Gardier AM, Landry DW, Denny CA. Neuropsychopharmacology. 2020 Aug;45(9):1545-1556.
PMID: 32417852
Presenter: Christine Denny, Assistant Professor of Clinical Neurobiology (in Psychiatry), Columbia University, New York
About Ketamine International Journal Club
Organisers
To unsubscribe: unsubscribe.kijc@ketamineconference.org